About Exactech (NASDAQ:EXAC)

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:EXAC
CUSIP30064E10
Phone+1-352-3771140
Debt
Debt-to-Equity Ratio0.06%
Current Ratio4.08%
Quick Ratio2.09%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E Ratio37.88
P/E Growth3.66
Sales & Book Value
Annual Sales$257.57 million
Price / Sales2.76
Cash Flow$2.5413 per share
Price / Cash19.38
Book Value$16.51 per share
Price / Book2.98
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$160,000.00
Net Margins4.72%
Return on Equity4.62%
Return on Assets3.82%
Miscellaneous
Employees733
Outstanding Shares14,420,000
Exactech (NASDAQ:EXAC) Frequently Asked Questions
What is Exactech's stock symbol?
Exactech trades on the NASDAQ under the ticker symbol "EXAC."
How were Exactech's earnings last quarter?
Exactech, Inc. (NASDAQ:EXAC) announced its quarterly earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.23 by $0.03. The medical equipment provider earned $61.40 million during the quarter, compared to analyst estimates of $61.78 million. Exactech had a net margin of 4.72% and a return on equity of 4.62%. View Exactech's Earnings History.
What price target have analysts set for EXAC?
3 brokerages have issued 1-year price objectives for Exactech's shares. Their predictions range from $49.00 to $49.00. On average, they anticipate Exactech's share price to reach $49.00 in the next year. View Analyst Ratings for Exactech.
Who are Exactech's key executives?
Exactech's management team includes the folowing people:
- R. William Petty M.D., Executive Chairman of the Board (Age 74)
- David W. Petty, Chief Executive Officer, President and Director (Age 50)
- Joel C. Phillips CPA, Chief Financial Officer, Executive Vice President, Treasurer (Age 49)
- Bruce E. Thompson, Senior Vice President , General manager- Biologics and Spine Division (Age 59)
- Gary J. Miller Ph.D., Executive Vice President - Research and Development (Age 69)
- Donna M. Edwards, Vice President, Legal and General Counsel (Age 44)
- Betty A. Petty, Vice President - Administration, Corporate Secretary (Age 74)
- James G. Binch, Independent Director (Age 69)
- W. Andrew Krusen Jr., Independent Director (Age 68)
- William B. Locander Ph.D., Independent Director (Age 73)
Has Exactech been receiving favorable news coverage?
News coverage about EXAC stock has trended somewhat positive on Thursday, according to Accern. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Exactech earned a media sentiment score of 0.10 on Accern's scale. They also assigned news headlines about the medical equipment provider an impact score of 46.64 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Exactech?
Shares of EXAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Exactech's stock price today?
One share of EXAC stock can currently be purchased for approximately $49.25.
How big of a company is Exactech?
Exactech has a market capitalization of $707.53 million and generates $257.57 million in revenue each year. Exactech employs 733 workers across the globe.
How can I contact Exactech?
Exactech's mailing address is 2320 NW 66th Ct, GAINESVILLE, FL 32653-1630, United States. The medical equipment provider can be reached via phone at +1-352-3771140 or via email at [email protected]
MarketBeat Community Rating for Exactech (EXAC)
MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe EXAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Exactech (NASDAQ:EXAC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Exactech in the last 12 months. Their average twelve-month price target is $49.00, suggesting that the stock has a possible downside of 0.51%. The high price target for EXAC is $49.00 and the low price target for EXAC is $49.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
Consensus Rating: | Hold | Hold | Hold | Hold |
Consensus Rating Score: | 2.00 | 2.00 | 2.00 | 2.00 |
Ratings Breakdown: | 0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s) |
Consensus Price Target: | $49.00 | $49.00 | $49.00 | $42.00 |
Price Target Upside: | 0.51% downside | 3.07% downside | 3.07% downside | 0.36% upside |
Exactech (NASDAQ:EXAC) Consensus Price Target History

Exactech (NASDAQ:EXAC) Analyst Ratings History
Show:
Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
---|
12/7/2017 | Robert W. Baird | Reiterated Rating | Hold | $49.00 | Low |  |
10/24/2017 | Gabelli | Downgrade | Buy -> Hold | | N/A |  |
10/23/2017 | Sidoti | Downgrade | Buy -> Neutral | | N/A |  |
(Data available from 4/26/2016 forward)
Exactech (NASDAQ:EXAC) Dividend History by Quarter
Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
---|
(Data available from 1/1/2013 forward)
Exactech (NASDAQ EXAC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 61.22%
Exactech (NASDAQ EXAC) Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
8/8/2017 | Fern Watts | Director | Sell | 1,013 | $29.04 | $29,417.52 | 4,727 | |
8/4/2017 | James G Binch | Director | Sell | 747 | $28.40 | $21,214.80 | 3,554 | |
5/31/2017 | William B Locander | Director | Sell | 988 | $30.34 | $29,975.92 | 8,555 | |
5/23/2017 | Joel C Phillips | CFO | Sell | 7,610 | $30.71 | $233,703.10 | 99,907 | |
3/9/2017 | Fern Watts | Director | Sell | 1,000 | $24.25 | $24,250.00 | 5,101 | |
3/8/2017 | James G Binch | Director | Sell | 3,588 | $24.16 | $86,686.08 | 6,850 | |
3/1/2017 | William B Locander | Director | Sell | 1,823 | $24.52 | $44,699.96 | 7,801 | |
2/24/2017 | Bruce E Thompson | SVP | Sell | 4,906 | $24.77 | $121,521.62 | 27,937 | |
11/3/2016 | James G Binch | Director | Sell | 600 | $22.61 | $13,566.00 | 5,682 | |
8/25/2016 | Fern Watts | Director | Sell | 1,100 | $27.68 | $30,448.00 | 4,936 | |
8/22/2016 | Bruce E Thompson | SVP | Sell | 1,433 | $27.97 | $40,081.01 | 25,375 | |
8/19/2016 | David W Petty | CEO | Sell | 3,550 | $27.75 | $98,512.50 | 63,122 | |
7/1/2016 | Joel C Phillips | CFO | Sell | 3,000 | $26.75 | $80,250.00 | 101,632 | |
6/8/2016 | Gary J Miller | EVP | Sell | 9,800 | $25.16 | $246,568.00 | 30,914 | |
6/7/2016 | Bruce E Thompson | SVP | Sell | 2,000 | $25.07 | $50,140.00 | 25,647 | |
6/3/2016 | James G Binch | Director | Sell | 600 | $24.86 | $14,916.00 | 5,585 | |
6/2/2016 | Gary J Miller | EVP | Sell | 3,381 | $25.11 | $84,896.91 | 30,914 | |
5/25/2016 | Gary J Miller | EVP | Sell | 9,319 | $25.10 | $233,906.90 | 30,914 | |
5/18/2016 | Gary J Miller | EVP | Sell | 9,664 | $24.37 | $235,511.68 | 30,914 | |
5/9/2016 | Joel C Phillips | CFO | Sell | 3,900 | $23.13 | $90,207.00 | 100,632 | |
5/5/2016 | James G Binch | Director | Sell | 1,870 | $23.00 | $43,010.00 | 5,400 | |
5/3/2016 | Fern Watts | Director | Sell | 2,000 | $22.76 | $45,520.00 | 6,251 | |
4/29/2016 | Betty A Petty | VP | Sell | 18,000 | $22.65 | $407,700.00 | 70,400 | |
4/27/2016 | Gary J Miller | EVP | Sell | 9,851 | $24.06 | $237,015.06 | 30,914 | |
4/26/2016 | Gary J Miller | EVP | Sell | 7,985 | $23.11 | $184,533.35 | 30,914 | |
4/25/2016 | Gary J Miller | EVP | Sell | 4,725 | $23.14 | $109,336.50 | 30,914 | |
3/31/2016 | Gary J Miller | EVP | Sell | 7,000 | $19.95 | $139,650.00 | 30,914 | |
3/10/2016 | Joel C Phillips | CFO | Sell | 2,000 | $18.58 | $37,160.00 | 104,226 | |
3/8/2016 | Betty A Petty | VP | Sell | 15,964 | $19.06 | $304,273.84 | 79,627 | |
3/7/2016 | Donna M Edwards | VP | Sell | 10,000 | $18.85 | $188,500.00 | 19,795 | |
3/3/2016 | Gary J Miller | EVP | Sell | 7,017 | $19.23 | $134,936.91 | 37,914 | |
3/3/2016 | William B Locander | Director | Sell | 2,435 | $19.25 | $46,873.75 | 4,866 | |
12/10/2015 | James G Binch | Director | Sell | 1,500 | $17.03 | $25,545.00 | 7,232 | |
12/9/2015 | Fern Watts | Director | Sell | 1,200 | $17.32 | $20,784.00 | 6,213 | |
12/1/2015 | Bruce E. Thompson | SVP | Sell | 21,904 | $17.57 | $384,853.28 | 23,139 | |
11/24/2015 | Bruce E. Thompson | SVP | Sell | 900 | $17.75 | $15,975.00 | 23,139 | |
9/1/2015 | Bruce E. Thompson | SVP | Sell | 2,107 | $19.45 | $40,981.15 | 22,780 | |
5/28/2015 | Joel C Phillips | CFO | Sell | 5,000 | $21.76 | $108,800.00 | | |
5/20/2015 | William B Locander | Director | Sell | 3,350 | $21.50 | $72,025.00 | | |
5/18/2015 | Fern Watts | Director | Sell | 2,200 | $21.21 | $46,662.00 | | |
5/4/2015 | Joel C Phillips | CFO | Sell | 2,700 | $21.67 | $58,509.00 | | |
3/20/2015 | Gary J Miller | EVP | Sell | 32,800 | $24.95 | $818,360.00 | | |
2/24/2015 | R William Petty | Chairman | Sell | 45,067 | $23.08 | $1,040,146.36 | | |
2/2/2015 | Betty A Petty | VP | Sell | 7,500 | $20.74 | $155,550.00 | | |
1/8/2015 | Gary J Miller | EVP | Sell | 4,145 | $23.17 | $96,039.65 | | |
12/3/2014 | Gary J Miller | EVP | Sell | 5,000 | $21.83 | $109,150.00 | | |
11/25/2014 | Betty A Petty | Major Shareholder | Sell | 12,500 | $21.86 | $273,250.00 | | |
11/25/2014 | Bruce E Thompson | SVP | Sell | 6,500 | $22.05 | $143,325.00 | | |
10/31/2014 | Joel C Phillips | CFO | Sell | 5,000 | $21.44 | $107,200.00 | | |
9/5/2014 | R William Petty | Major Shareholder | Sell | 25,000 | $23.68 | $592,000.00 | | |
8/25/2014 | Albert H Burstein | Director | Sell | 8,852 | $23.73 | $210,057.96 | | |
7/1/2014 | Gary J Miller | EVP | Sell | 12,392 | $26.21 | $324,794.32 | | |
6/26/2014 | Gary J Miller | EVP | Sell | 1,894 | $25.06 | $47,463.64 | | |
6/25/2014 | Gary J Miller | EVP | Sell | 16,356 | $25.33 | $414,297.48 | | |
6/10/2014 | Joel C Phillips | CFO | Sell | 5,000 | $24.77 | $123,850.00 | | |
6/5/2014 | Bruce E Thompson | SVP | Sell | 1,667 | $23.50 | $39,174.50 | | |
6/5/2014 | Joel C Phillips | CFO | Sell | 5,000 | $23.21 | $116,050.00 | | |
5/29/2014 | Bruce E Thompson | SVP | Sell | 1,588 | $23.00 | $36,524.00 | | |
5/12/2014 | David Petty | CEO | Sell | 10,287 | $20.99 | $215,924.13 | 69,253 | |
5/8/2014 | David Petty | CEO | Sell | 7,976 | $21.51 | $171,563.76 | 67,516 | |
4/24/2014 | Bruce Thompson | SVP | Sell | 2,412 | $23.78 | $57,357.36 | 16,241 | |
4/23/2014 | William Locander | Director | Sell | 4,500 | $23.18 | $104,310.00 | 3,724 | |
2/28/2014 | William Locander | Director | Sell | 1,819 | $23.16 | $42,128.04 | 8,224 | |
12/5/2013 | R William Petty | CEO | Sell | 10,000 | $23.67 | $236,700.00 | 99,400 | |
11/12/2013 | Bruce Thompson | SVP | Sell | 3,079 | $23.35 | $71,894.65 | 18,074 | |
8/22/2013 | William Locander | Director | Sell | 1,521 | $19.05 | $28,975.05 | 7,640 | |
7/15/2013 | Gary J Miller | EVP | Sell | 10,250 | $20.07 | $205,717.50 | | |
7/8/2013 | Gary J Miller | EVP | Sell | 1,000 | $20.00 | $20,000.00 | | |
6/17/2013 | Gary J Miller | EVP | Sell | 8,125 | $18.98 | $154,212.50 | | |
6/5/2013 | R William Petty | CEO | Sell | 3,885 | $18.00 | $69,930.00 | | |
6/4/2013 | R William Petty | CEO | Sell | 14,257 | $18.01 | $256,768.57 | | |
5/28/2013 | R William Petty | CEO | Sell | 20,000 | $18.21 | $364,200.00 | | |
5/22/2013 | R William Petty | CEO | Sell | 11,493 | $18.13 | $208,368.09 | | |
5/17/2013 | R William Petty | CEO | Sell | 17,472 | $18.05 | $315,369.60 | | |
5/16/2013 | R William Petty | CEO | Sell | 22,893 | $18.22 | $417,110.46 | | |
5/9/2013 | R William Petty | CEO | Sell | 10,000 | $18.25 | $182,500.00 | | |
5/8/2013 | David W Petty | President | Sell | 8,000 | $18.35 | $146,800.00 | | |
12/4/2012 | R William Petty | CEO | Sell | 14,048 | $16.29 | $228,841.92 | | |
(Data available from 1/1/2013 forward)
Exactech (NASDAQ EXAC) News Headlines
Source: |
|
Date | Headline |
---|
 | Exactech, Inc. (EXAC) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 18 at 7:24 PM |
 | Exactech (EXAC) Lowered to Sell at BidaskClub www.americanbankingnews.com - April 14 at 11:25 PM |
 | Robert W. Baird Analysts Give Exactech (EXAC) a $34.00 Price Target www.americanbankingnews.com - April 7 at 12:48 PM |
 | Exactech (EXAC) Rating Lowered to Hold at Gabelli www.americanbankingnews.com - April 5 at 9:00 PM |
 | Exactech Knee Research Honored with Orthopaedic Research Society’s Best Implant Poster Award www.bizjournals.com - April 3 at 4:29 PM |
 | Comparing Covidien (COV) & Exactech (EXAC) www.americanbankingnews.com - March 28 at 7:18 PM |
 | Exactech (EXAC) vs. Asante Solutions (PUMP) Critical Analysis www.americanbankingnews.com - March 27 at 1:39 AM |
 | BidaskClub Lowers Exactech (EXAC) to Strong Sell www.americanbankingnews.com - March 26 at 2:30 PM |
 | Exactech (EXAC) Rating Increased to Hold at BidaskClub www.americanbankingnews.com - March 25 at 3:12 PM |
 | 63,624 Shares in Exactech, Inc. (EXAC) Purchased by Koch Industries Inc. www.americanbankingnews.com - March 5 at 3:42 PM |
 | Martingale Asset Management L P Sells 30,602 Shares of Exactech, Inc. (EXAC) www.americanbankingnews.com - March 4 at 12:50 PM |
 | Kennedy Capital Management Inc. Takes Position in Exactech, Inc. (EXAC) www.americanbankingnews.com - March 3 at 3:30 PM |
 | Exactech, Inc. (EXAC) Shares Sold by Royce & Associates LP www.americanbankingnews.com - March 3 at 9:12 AM |
 | Water Island Capital LLC Acquires New Holdings in Exactech, Inc. (EXAC) www.americanbankingnews.com - March 2 at 9:38 PM |
 | Spark Investment Management LLC Lowers Position in Exactech, Inc. (EXAC) www.americanbankingnews.com - March 1 at 6:50 PM |
 | Exactech, Inc. (EXAC) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - February 27 at 9:30 PM |
 | Harvest Management LLC Invests $3.23 Million in Exactech, Inc. (EXAC) www.americanbankingnews.com - February 27 at 3:00 PM |
 | K2 Principal Fund L.P. Invests $5.02 Million in Exactech, Inc. (EXAC) Stock www.americanbankingnews.com - February 26 at 3:12 PM |
 | With A -96.98% Earnings Drop Lately, Did Exactech Inc (NASDAQ:EXAC) Underperform Its Industry? finance.yahoo.com - February 19 at 9:03 AM |
 | BidaskClub Lowers Exactech (EXAC) to Sell www.americanbankingnews.com - February 17 at 11:00 PM |
 | Exactech (EXAC) Gets Acquired by TPG Capital, Goes Private www.zacks.com - February 15 at 8:46 AM |
 | Exactech Announces Completion of Merger with TPG Capital finance.yahoo.com - February 14 at 4:47 PM |
 | Exactech (EXAC) Scheduled to Post Quarterly Earnings on Monday www.americanbankingnews.com - February 12 at 3:02 AM |
 | Critical Contrast: NuVasive (NUVA) versus Exactech (EXAC) www.americanbankingnews.com - February 12 at 1:16 AM |
 | Exactech, Inc. (EXAC) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - February 2 at 9:24 PM |
 | Exactech (EXAC) & Palomar Medical Technologies (PMTI) Critical Analysis www.americanbankingnews.com - January 29 at 1:12 AM |
 | Osteon Merger Sub, Inc. -- Moody's assigns B2 Corporate Family Rating to acquirer of Exactech finance.yahoo.com - January 25 at 9:08 AM |
 | Exactech (EXAC) Cut to Sell at BidaskClub www.americanbankingnews.com - January 20 at 10:28 AM |
 | The Europe Shoulder Arthroplasty Market would witness market growth of 7.5% CAGR during the forecast period (2017 - 2023) www.bizjournals.com - January 11 at 9:47 AM |
 | Exactech, Inc. :EXAC-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 finance.yahoo.com - January 1 at 9:25 AM |
 | The Global Shoulder Arthroplasty Market is expected to reach $ 1,866.3 million by 2023 www.bizjournals.com - December 29 at 5:17 PM |
 | LAWSUIT ALERT – Andrews & Springer LLC Announces That A Securities Class Action Has Been Filed Against Exactech, Inc. - EXAC finance.yahoo.com - December 28 at 3:03 PM |
 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC finance.yahoo.com - December 28 at 3:03 PM |
 | Exactech (EXAC) Upgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - December 26 at 9:52 PM |
 | Comparing Zimmer Biomet (ZBH) and Exactech (EXAC) www.americanbankingnews.com - December 24 at 12:40 AM |
 | EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc. finance.yahoo.com - December 21 at 9:28 AM |
 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC finance.yahoo.com - December 15 at 5:57 PM |
 | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Exactech, Inc. (EXAC) www.prnewswire.com - December 15 at 10:33 AM |
 | Exactech, Inc. (EXAC) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - December 14 at 11:32 PM |
 | EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc. finance.yahoo.com - December 14 at 9:35 AM |
 | EXACTECH MERGER INVESTIGATION ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Exactech, Inc. feeds.benzinga.com - December 13 at 8:33 PM |
 | ETFs with exposure to Exactech, Inc. : December 7, 2017 finance.yahoo.com - December 7 at 5:48 PM |
 | Exactech Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing System finance.yahoo.com - December 7 at 5:48 PM |
 | Exactech's (EXAC) Hold Rating Reaffirmed at Robert W. Baird www.americanbankingnews.com - December 7 at 7:56 AM |
 | Wall Street's M&A Chatter From December 4: Prysmian-General Cable, Exactech-TPG Capital, TTM Technologies-Anaren www.benzinga.com - December 5 at 10:09 AM |
 | Exactech (EXAC), TPG Capital Amend Merger Agreement Providing for Increase in Consideration to $49.25/Share www.streetinsider.com - December 5 at 10:09 AM |
 | BRIEF-Exactech And TPG Capital Announce Amended Merger Agreement With Increase In Merger Consideration To $49.25 Per Share www.businessinsider.com - December 5 at 10:09 AM |
 | Exactech Inc. (EXAC) Jumped To A New High After Amended Merger Agreement www.rttnews.com - December 5 at 10:09 AM |
 | Exactech gets higher $737 million cash offer from TPG Capital www.reuters.com - December 5 at 10:09 AM |
 | ACT NOW: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC finance.yahoo.com - December 4 at 5:20 PM |
Exactech (NASDAQ:EXAC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Exactech (NASDAQ:EXAC) Income Statement, Balance Sheet and Cash Flow Statement
Exactech (NASDAQ EXAC) Stock Chart for Thursday, April, 26, 2018
Loading chart…